July 4, 2025 - 02:42

Honeywell has announced its acquisition of Nexceris' Li-ion Tamer business, a move that enhances its capabilities in fire safety technology. The Li-ion Tamer technology specializes in off-gas detection, offering a sophisticated solution that provides early warnings of thermal runaway incidents in lithium-ion batteries. This acquisition represents a significant addition to Honeywell's existing fire safety technology portfolio within its Building Automation segment.
The integration of Li-ion Tamer’s innovative detection solutions aligns with Honeywell's commitment to improving safety standards in various industries, particularly as the use of lithium-ion batteries continues to rise. This strategic acquisition builds upon a five-year partnership between Honeywell and Nexceris, aimed at advancing battery safety measures. By incorporating this cutting-edge technology, Honeywell is poised to deliver enhanced safety solutions that can effectively mitigate risks associated with lithium-ion batteries, ensuring a safer environment for users and facilities alike.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...